CKD anemia due to decreased erythropoietin; which finding is most likely?

Enhance your PEAT Series 2 Form B Test preparation with structured questions and detailed insights. Understand test formats with explanations and ace your exam!

Multiple Choice

CKD anemia due to decreased erythropoietin; which finding is most likely?

Explanation:
Chronic kidney disease lowers erythropoietin production, which reduces the bone marrow’s red blood cell output. With less EPO signaling, fewer RBCs are made, so the hematocrit (and hemoglobin) drop, producing anemia. A high white blood cell count doesn’t stem from this hormonal deficiency, and the key change isn’t a normal RBC lifespan. Platelet counts aren’t specifically driven higher by EPO loss in CKD. The most likely finding is a low hematocrit, reflecting decreased RBC production; reticulocyte count would also be expected to be low due to reduced marrow activity.

Chronic kidney disease lowers erythropoietin production, which reduces the bone marrow’s red blood cell output. With less EPO signaling, fewer RBCs are made, so the hematocrit (and hemoglobin) drop, producing anemia. A high white blood cell count doesn’t stem from this hormonal deficiency, and the key change isn’t a normal RBC lifespan. Platelet counts aren’t specifically driven higher by EPO loss in CKD. The most likely finding is a low hematocrit, reflecting decreased RBC production; reticulocyte count would also be expected to be low due to reduced marrow activity.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy